Researchers collected milk samples at three time points: immediately before the weekly dose (time zero), 12 hours after the dose, and 24 hours after the dose
During the subsequent 17-week off-treatment period, the patients began to regain weight and showed some increases in type 2 diabetes progression, resulting in a 88% diabetes risk reduction after the off-period
Additional patient groups requiring careful consideration or alternative treatment options include those with severe gastrointestinal disease, including gastroparesis, as tirzepatide delays gastric emptying
Insurance Coverage for Mounjaro (Type 2 Diabetes) In normal cases, insurance plans cover Mounjaro when prescribed for type 2 diabetes
Regeneron materials described in this manuscript, or comparable alternatives, may be available to academic researchers upon request through our portal: under a material transfer agreement
How do I know if I am using a U-100 syringe